The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable nonmetastatic pancreatic cancer (PC).
 
Sarah E. Hoffe
Stock and Other Ownership Interests - Vit Inc
Honoraria - UpToDate
Consulting or Advisory Role - Merck
Research Funding - Galera Therapeutics (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - I co-wrote the bone metastases chapter for UpToDate. They pay royalties/honoraria for that yearly.
Travel, Accommodations, Expenses - Varian Medical Systems
Other Relationship - Beyond the White Coat; Vit Inc
(OPTIONAL) Uncompensated Relationships - Galera Therapeutics; ViewRay
 
Dae Won Kim
No Relationships to Disclose
 
James Costello
Stock and Other Ownership Interests - AstraZeneca; ViewRay
Travel, Accommodations, Expenses - Siemens
 
Mokenge Peter Malafa
No Relationships to Disclose
 
Todd Anthony Aguilera
Stock and Other Ownership Interests - AKSO Biopharmaceutical; Avelas Biosciences
Consulting or Advisory Role - Apexigen
Research Funding - Apexigen (Inst); Galera Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent from Stanford with royalties for licensing to Akso Biosciences; Patent from UCSD with royalties for licensing to Avelas Biosciences
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; AstraZeneca/MedImmune; Cancer Commons; Ipsen; Legend Biotech
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Parag Parikh
Stock and Other Ownership Interests - Nuvaira
Honoraria - ViewRay
Speakers' Bureau - Viewray
Research Funding - ViewRay (Inst)
Travel, Accommodations, Expenses - IBA
 
Joseph M. Herman
Honoraria - Sirtex Medical
Travel, Accommodations, Expenses - Varian Medical Systems; Varian Medical Systems
 
Jon Holmlund
Employment - Galera Therapeutics
Leadership - Galera Therapeutics
Stock and Other Ownership Interests - Galera Therapeutics
Consulting or Advisory Role - Aspire IRB/WIRB-Copernicus; OncoNano Inc; Prometheus
 
Kara Terry
Employment - Galera Therapeutics
Stock and Other Ownership Interests - Galera Therapeutics
 
Elizabeth Charlotte Moser
Employment - Galectin Therapeutics
Stock and Other Ownership Interests - Galera Therapeutics